High BRCA2 mRNA expression predicts poor prognosis in breast cancer patients

International Journal of Cancer

Volumn 98, Issue 6, 2002, Pages 879-882

  Egawa, Chiyomi ^a   Miyoshi, Yasuo ^a   Taguchi, Tetsuya ^a   Tamaki, Yasuhiro ^a   Noguchi, Shinzaburo ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

BRCA2; Breast cancer; ER; Histologic grade; Prognosis

Indexed keywords

BETA GLUCURONIDASE; BRCA2 PROTEIN; ESTROGEN RECEPTOR; MESSENGER RNA;

ARTICLE; BREAST CANCER; CANCER GRADING; CANCER SIZE; CANCER SURVIVAL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MENOPAUSE; PRIORITY JOURNAL; PROGNOSIS;

BRCA2 PROTEIN; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GENE EXPRESSION; HUMANS; LYMPHATIC METASTASIS; MENOPAUSE; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, ESTROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM;

EID: 0037140101     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.10231     Document Type: Article

References (30)

1. Characteristics of small breast and/or ovarian cancer families with germline mutations in BRCA1 and BRCA2
2. Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in Taiwan
3. Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families
4. Frequency of BRCA1 and BRCA2 germline mutations in Japanese breast cancer families
5. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer
6. Different rumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13
7. Insights into the functions of BRCA1 and BRCA2
8. The RING heterodimer BRCA1-BARD1 is a ubiquitin ligase inactivated by a breast cancer-derived mutation
9. Somatic mutations in the BRCA1 gene in Chinese sporadic breast and ovarian cancer
10. Mutation analysis in the BRCA2 gene in primary breast cancers
11. BRCA2 mutations in primary breast and ovarian cancers
12. A somatic truncating mutation in BRCA2 in a sporadic breast tumor
13. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression
14. Aberrant methylation of the BRCA1 CpG island promoter is associated with decreased BRCA1 mRNA in sporadic breast cancer cells
15. Overexpression of BRCA2 gene in sporadic breast tumours
16. Absence of methylation of CpG dinucleotides within the promoter of the breast cancer susceptibility gene BRCA2 in normal tissues and in breast and ovarian cancers
17. An important role for BRCA1 in breast cancer progression is indicated by its loss in a large proportion of non-familial breast cancers
18. Immunolocalization of BRCA1 protein in normal breast tissue and sporadic invasive ductal carcinomas: A correlation with other biological parameters
19. BRCA1 expression levels predict distant metastasis of sporadic breast cancers
20. Quantitative analysis of BRCA1 and BRCA2 mRNA expression in sporadic breast carcinomas and its relationship with clinicopathological characteristics
21. Decreased expression of BRCA2 mRNA predicts favorable response to docetaxel in breast cancer
22. Fifth International Conference on Adjuvant Therapy of Breast Cancer
23. Meeting highlights: International concensus panel on the treatment of primary breast cancer
24. Grading of invasive carcinoma of the breast
25. Brca2 is coordinately regulated with Brca1 during proliferation and differentiation in mammary epithelial cells
26. S-phase fraction and DNA ploidy in 633 T1T2 breast cancers: A standardized flow cytometric study
27. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: An implication for mutator phenotype and breast cancer pathogenesis
28. Clinicopathological analysis of breast cancers with chromosomal aneusomy detected by fluorescence in situ hybridization
29. BRCA2 protein expression in sporadic breast carcinoma with or without allelic loss of BRCA2
30. Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer